Published in Lancet on June 12, 2011
Vaccine hesitancy: an overview. Hum Vaccin Immunother (2013) 1.96
Urban settings do not ensure access to services: findings from the immunisation programme in Kampala Uganda. BMC Health Serv Res (2014) 0.91
Vaccine discovery and translation of new vaccine technology. Lancet (2011) 1.51
Vaccine production, distribution, access, and uptake. Lancet (2011) 1.49
Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med (2008) 17.12
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (2010) 13.86
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med (2003) 7.39
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet (2011) 5.43
Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet (2013) 3.98
The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study. Clin Infect Dis (2012) 3.40
Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ (2005) 3.36
Pneumococcal vaccination in developing countries. Lancet (2006) 2.45
Worldwide emergence of multiple clades of enterovirus 68. J Gen Virol (2012) 2.35
Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine (2007) 2.07
Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet (2009) 1.95
Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med (2014) 1.84
Pneumococcal pneumonia and influenza: a deadly combination. Vaccine (2009) 1.78
Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. Clin Infect Dis (2010) 1.62
Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010. J Infect Dis (2012) 1.61
Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS (2012) 1.59
Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis (2013) 1.55
Pneumococcal vaccines and flu preparedness. Science (2007) 1.50
The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol (2010) 1.43
Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa. Int J Antimicrob Agents (2008) 1.40
Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis (2012) 1.38
The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS (2002) 1.34
Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study. Pediatr Infect Dis J (2010) 1.33
HIV and pneumococcal disease. Curr Opin Infect Dis (2007) 1.30
The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J Infect Dis (2006) 1.30
Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatr Infect Dis J (2009) 1.29
Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin Infect Dis (2008) 1.29
Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol (2006) 1.26
Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines. Clin Vaccine Immunol (2009) 1.25
High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis (2011) 1.24
Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America. Clin Infect Dis (2012) 1.24
Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa. PLoS One (2012) 1.21
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews. BMC Public Health (2012) 1.20
The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS (2011) 1.19
Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads. PLoS One (2011) 1.19
Human metapneumovirus genetic variability, South Africa. Emerg Infect Dis (2005) 1.15
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infect Dis (2012) 1.12
Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining? Lancet Infect Dis (2006) 1.11
Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program. PLoS One (2011) 1.08
Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009. Clin Infect Dis (2014) 1.07
Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa. Pediatr Infect Dis J (2012) 1.06
Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008. Vaccine (2013) 1.04
Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010-2011. J Infect Dis (2013) 1.04
Childhood pneumonia--progress and challenges. S Afr Med J (2006) 1.02
Maternal HIV infection and vertical transmission of pathogenic bacteria. Pediatrics (2012) 1.00
Conserved mutations in the pneumococcal bacteriocin transporter gene, blpA, result in a complex population consisting of producers and cheaters. MBio (2011) 1.00
Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. J Infect Dis (2013) 0.97
HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis (2013) 0.96
Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and -uninfected adults with pneumococcal bacteremia. J Infect Dis (2004) 0.94
Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother (2012) 0.93
Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study. PLoS One (2011) 0.91
Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1). Emerg Infect Dis (2015) 0.91
Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: potential benefits of rotavirus vaccine. Vaccine (2012) 0.91
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life. BMC Med (2014) 0.90
Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS (2014) 0.90
Use of 2 pneumococcal common protein real-time polymerase chain reaction assays in healthy children colonized with Streptococcus pneumoniae. Diagn Microbiol Infect Dis (2011) 0.90
Epidemiology of viral-associated acute lower respiratory tract infection among children <5 years of age in a high HIV prevalence setting, South Africa, 2009-2012. Pediatr Infect Dis J (2015) 0.90
Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. Vaccine (2011) 0.89
Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization. Pediatr Infect Dis J (2013) 0.88
Dynamics of pneumococcal transmission in vaccine-naive children and their HIV-infected or HIV-uninfected mothers during the first 2 years of life. Am J Epidemiol (2013) 0.88
Distribution of pilus islands of group B streptococcus associated with maternal colonization and invasive disease in South Africa. J Med Microbiol (2012) 0.88
Systematic review on the etiology and antibiotic treatment of pneumonia in human immunodeficiency virus-infected children. Pediatr Infect Dis J (2011) 0.88
Impact of the antiretroviral treatment program on the burden of hospitalization for culture-confirmed tuberculosis in South African children: a time-series analysis. Pediatr Infect Dis J (2013) 0.88
Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines. Vaccine (2009) 0.87
Review on the immunogenicity and safety of PCV-13 in infants and toddlers. Expert Rev Vaccines (2011) 0.87
A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children. J Infect Dis (2009) 0.87
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination. AIDS (2015) 0.87
Herd immunity after pneumococcal conjugate vaccination. Lancet (2007) 0.87
An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa. J Clin Microbiol (2009) 0.86
Evaluation of Trans-Vag broth, colistin-nalidixic agar, and CHROMagar StrepB for detection of group B Streptococcus in vaginal and rectal swabs from pregnant women in South Africa. J Clin Microbiol (2013) 0.86
A DTaP-IPV//PRP∼T vaccine (Pentaxim): a review of 16 years' clinical experience. Expert Rev Vaccines (2011) 0.85
Acquisition of Streptococcus pneumoniae in pneumococcal conjugate vaccine-naïve South African children and their mothers. Pediatr Infect Dis J (2013) 0.85
Economic burden of acute lower respiratory tract infection in South African children. Paediatr Int Child Health (2012) 0.84
Apnea and its possible relationship to immunization in ex-premature infants. Vaccine (2008) 0.84
Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. AIDS (2013) 0.83
Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina. Pediatr Infect Dis J (2004) 0.83
South African guideline for the diagnosis, management and prevention of acute viral bronchiolitis in children. S Afr Med J (2010) 0.83
The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative. Pan Afr Med J (2011) 0.83
Review of guidelines for evidence-based management for childhood community-acquired pneumonia in under-5 years from developed and developing countries. Pediatr Infect Dis J (2013) 0.82
The case for launch of an international DNA-based birth cohort study. J Glob Health (2011) 0.82
Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization program. Pediatr Infect Dis J (2013) 0.82
Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants. Expert Rev Vaccines (2014) 0.82
Deaths associated with respiratory syncytial and influenza viruses among persons ≥5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). Emerg Infect Dis (2015) 0.82
Influenza vaccination of pregnant women and protection of their infants. N Engl J Med (2014) 0.80
The discriminative value of C-reactive protein levels in distinguishing between community-acquired bacteraemic and respiratory virus-associated lower respiratory tract infections in HIV-1-infected and -uninfected children. Ann Trop Paediatr (2002) 0.80
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study. BMC Res Notes (2011) 0.80
Evolutionary dynamics of 2009 pandemic influenza A virus subtype H1N1 in South Africa during 2009-2010. J Infect Dis (2012) 0.80
Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013. Emerg Infect Dis (2016) 0.79
Impact of Rotavirus Vaccine on Childhood Diarrheal Hospitalization Following Introduction into the South African Public Immunization Program. Pediatr Infect Dis J (2013) 0.79
Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Ther Drug Monit (2012) 0.79
Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study. BMC Pediatr (2011) 0.79
Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012. Pediatr Infect Dis J (2015) 0.78
Risk Factors for Presumed Bacterial Pneumonia Among HIV-uninfected Children Hospitalized in Soweto, South Africa. Pediatr Infect Dis J (2016) 0.78
Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants. PLoS One (2013) 0.77
Benefits to mother and child of influenza vaccination during pregnancy. Hum Vaccin Immunother (2012) 0.77
Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa. Influenza Other Respir Viruses (2014) 0.77
Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections. Curr Opin Infect Dis (2016) 0.76
Hospitalization for Culture-confirmed Pulmonary Tuberculosis in the Era of Childhood Pneumococcal Conjugate Vaccine Immunization. Pediatr Infect Dis J (2017) 0.76
Co-trimoxazole prophylaxis in African children with HIV-1. Lancet (2005) 0.76